Annonseinntekter står på spill: Gjør deg klar for å overholde Digital Markets Act (DMA) med Usercentrics
Usercentrics, som er en ledende leverandør av løsninger for samtykkeadministrasjon, har rapportert et sjokkerende antall bedrifter som ikke overholder personvernforordningen i flere bransjer i EU. Denne mangelen på oppmerksomhet og prioritering av personvern og brukersamtykke kan bli mye mer risikabelt når Digital Markets Act (DMA) må håndheves fra og med 6. mars 2024.
Ingen inntekt uten samtykke: Digital Markets Act vekker annonsørene
Selv om DMA påvirker de seks selskapene som utestenger andre selskaper, og som er utpekt av EU-kommisjonen — Alphabet, Amazon, Apple, ByteDance, Meta og Microsoft — glemmer vi at det også vil påvirke alle selskaper som jobber med digitale virksomheter i EU og som er avhengig av de seks teknologigigantenes plattformer og tjenester.
«DMA kommer til å bli en vekker for mange bedrifter. Det betyr i utgangspunktet: Ingen inntekt uten samtykke. Det er ikke bare en tilleggsforskrift som krever at bedrifter med virksomhet i EU og EØS innhenter eksplisitt samtykke fra brukere før de behandler personopplysningene deres. I tillegg kommer selskapene som er nevnt ovenfor, sannsynligvis til å kreve at selskaper som bruker tjenestene deres til annonsering, e-handel, analyser med mer, må overholde og ta i bruk samtykkeadministrasjonsprosesser», forklarer Donna Dror, Usercentrics' administrerende direktør.
Det kan være svært kostbart og en stor risiko for disse selskapene å ikke overholde Digital Markets Act. Men det er ikke mindre risikabelt for tredjeparter å ikke overholde DMA, siden de også kan oppleve tap av data, publikum, inntekter og merkevarens omdømme. Dette kommer til å skje hvis de mister tilgangen til brukerdatabasen, opplysningene og tjenestene som Google, Meta og andre leverandører tilbyr.
Lagre annonseinntektene og analysedataene dine: Usercentrics gjør deg klar for DMA
Den gode nyheten er at det er enkelt å oppfylle og overholde kravene til Digital Markets Act og disse selskapene. Med Usercentrics' og Cookiebots™ plattform for samtykkehåndtering (CMP-er) kan bedrifter informere brukere, innhente og lagre gyldig samtykke og gi samtykke til disse selskapene.
Den patenterte dypskanningsteknologien og de automatiserte funksjonene oppdager, kategoriserer og administrerer informasjonskapsler (cookies) og sporingsteknologier som brukes på nettsider, apper og tilkoblede plattformer.
CMP-er gjør det enkelt å overholde DMA-personvernsamsvar ved å aktivere direkte integrering med ledende systemer for administrasjon av netthandel (CMS), inkludert WordPress, Magento, HubSpot, Joomla og Shopify. I tillegg gir de støtte for app- og TV-plattformer, samt rammeverk på tvers av plattformer som iOS, Android, Unity og React.
Ønsker du å vite mer om hvordan du kan klargjøre bedriften din for Digital Markets Act? Gå til usercentrics.com.
Hvis du vil se dette innholdet fra cts.businesswire.com, gi ditt samtykke øverst på denne siden.
Se kildeversjon på businesswire.com: https://www.businesswire.com/news/home/20231030052781/no/
Contact information
Hvis du har intervju- og presseforespørsler, kan du kontakte:
Hannah Sinz
PR-seniorrådgiver
pr@usercentrics.com
Om Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg pressemeldinger fra Business Wire
Registrer deg med din e-postadresse under for å få de nyeste sakene fra Business Wire på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra Business Wire
Transition Industries LLC and Macquarie Group Announce Marketing Agreement for Low Carbon Methanol Project in Sinaloa, Mexico11.12.2023 15:13:00 CET | Press release
Transition Industries LLC announced at COP 28 that it has entered into a Master Services and Marketing Agreement (MSMA) with Macquarie Commodities Trading, an affiliate of Macquarie Group’s Commodities and Global Markets business (“Macquarie” / “CGM”), for its Pacifico Mexinol project, a 6,145 MT per day methanol production facility near Topolobampo, Sinaloa, Mexico (“Pacifico Mexinol” or the “Project”). When it commences operations, Pacifico Mexinol is expected to be one of the largest single low carbon chemicals facilities in the world - producing approximately 300,000 MT of green methanol from captured carbon and green hydrogen and 1.8 million MT of blue methanol per year from natural gas with carbon capture. Under the terms of the MSMA, Macquarie is responsible for marketing all the production from Pacifico Mexinol to customers on a global basis in accordance with methanol offtake agreements, the provisioning of financial hedging services as required by the Project, and supporting
SLB Collaborates with Northern Lights JV and Microsoft to Digitalize Carbon Capture and Storage Value Chain11.12.2023 15:00:00 CET | Press release
SLB (NYSE: SLB) and Northern Lights Joint Venture (NL) announced today they have signed a memorandum of understanding (MoU) with Microsoft to optimize integrated cloud-based workflows for the operation of Northern Lights, one of the first CO2 transport and storage providers for cross-border carbon capture and storage (CCS). The collaboration will contribute to the development of scalable and cost-efficient digital solutions for the emerging CCS industry. “Digital workflows are a key component to successfully managing CO2 through the end-to-end value chain, from capture point to permanent storage. Northern Lights is very pleased to partner with industry leading tech companies, SLB and Microsoft, on the development of digital CCS solutions”, said Børre Jacobsen, Managing Director of Northern Lights. In the initial phases of the collaboration, SLB will extend its digital CCS workflows and numerical simulation systems on its Delfi™ digital platform, which was deployed to streamline the sub
New Post Hoc Analysis from MAVORIC Trial Sheds Light on the Burden of Cutaneous T-Cell Lymphoma on Health-Related Quality of Life11.12.2023 15:00:00 CET | Press release
Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co. Ltd, today announced health-related quality of life (HRQL) findings from a post hoc analysis of the MAVORIC trial in patients with mycosis fungoides (MF) or Sézary syndrome (SS), two subtypes of cutaneous T-cell lymphoma (CTCL). Researchers analysed baseline data collected prior to initiation of study treatment and found the symptoms of advanced MF/SS affected HRQL across all domains, with poorer HRQL associated with being younger in age, female, having moderate or severe itching, and impaired function as measured by the Eastern Cooperative Oncology Group performance status (ECOG PS). “CTCL is a chronic, life-long condition. Understanding how symptoms impact an individual physically, emotionally as well as in their daily life is critical,” said Susan Thornton, Chief Executive Officer, Cutaneous Lymphoma Foundation and one of the study authors. “The data provide new insights into the burdens of living with CTC
Battery Manufacturer Hithium Opens New 28 GWh Intelligent Production Plant11.12.2023 15:00:00 CET | Press release
Stationary energy storage expert Hithium will release 28 GWh planned production capacity successively at first stage of Phase 1 of its new base in Chongqing, China. The new plant is designed in line with "Intelligent Manufacturing 4.0" standards, including a 26% increase in automation over the typical "Intelligent Manufacturing 3.0" production system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231211098435/en/ Hithium Chongqing production plant (Photo: Business Wire) Hithium’s automation gains at Chongqing have resulted in an overall efficiency jump of 30%, as well as cost reductions amounting to a quarter of production overhead, delivering a significant lead in manufacturing competitiveness. Built with an investment of RMB13 billion ($1.8 billion), the site covers 800,000 m2 and is located in the Tongliang high-tech zone. The new capacity aims at helping to meet global demand for what is expected to be 720GW of energy s
BIO KOREA 2024 Opens for Program Registration and Exhibition Applications11.12.2023 15:00:00 CET | Press release
BIO KOREA 2024, jointly hosted by the Korea Health Industry Development Institute (KHIDI, President: Cha Soon-do) and Chungcheongbuk-do (Governor: Kim Young-hwan), commenced entry registration and exhibition participating company recruitment from December 4, 2023. The event will be held at COEX in Seoul, Korea from May 8th to 10th, 2024. BIO KOREA, marking its 19th edition in 2024, has established itself as the preeminent bio-industry event in Korea. For the past 18 years, BIO KOREA has served as a catalyst for business revitalization and technological exchange between domestic and foreign companies, fostering a vibrant ecosystem of innovation and collaboration within the biohealth sector. Held in May of this year, BIO KOREA 2023 witnessed the participation of approximately 29,400 individuals from 780 companies across 51 countries, resulting in around 1,300 business meetings. Additionally, approximately 330 companies from 18 countries showcased their technologies through approximately